Microarray Analysis in Alzheimer's Disease and Normal Aging

The purpose of this study was to investigate gene expression in Alzheimer's disease (AD), the most common form of senile dementia. We utilized the microarray technology to simultaneously compare the expression profile of 12,000 human genes in cerebral cortex of AD and normal aging. To identify gene expression related to neurodegeneration, beside the presence of amyloid deposition, we used control brains with abundant amyloid plaques, derived from cognitively normal elderly subjects. The microarray analysis indicated that 314 genes were differentially expressed in AD cerebral cortex, with differences greater than 5 folds in 25 genes. RT‐PCR performed on a selected group of genes confirmed the increased expression of the interferon‐induced protein 3 in AD brain. This protein, which is highly inducible by both type I and type II interferons, was not previously associated with the neurodegenerative disease. IUBMB Life, 56: 349‐354, 2004

[1]  S. Barger,et al.  S100β Increases Levels of β‐Amyloid Precursor Protein and Its Encoding mRNA in Rat Neuronal Cultures , 1998 .

[2]  Kazuyuki Takata,et al.  Cdk5 Is a Key Factor in Tau Aggregation and Tangle Formation In Vivo , 2003, Neuron.

[3]  D. Butterfield,et al.  Protein oxidation in the brain in Alzheimer's disease , 2001, Neuroscience.

[4]  S. M. Sumi,et al.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD) , 1991, Neurology.

[5]  R. Mrak,et al.  Interleukin-1, neuroinflammation, and Alzheimer’s disease , 2001, Neurobiology of Aging.

[6]  G. Gibson.  Interactions of oxidative stress with cellular calcium dynamics and glucose metabolism in Alzheimer's disease. , 2002, Free radical biology & medicine.

[7]  G. Stark,et al.  Molecular analysis of a human interferon-inducible gene family. , 1991, European journal of biochemistry.

[8]  Vicki Olm,et al.  Statin therapy for Alzheimer’s disease , 2002, Journal of Molecular Neuroscience.

[9]  J. Simpkins,et al.  Estrogens and Estrogen‐Like Non‐Feminizing Compounds: Their Role in the Prevention and Treatment of Alzheimer's Disease , 2000, Annals of the New York Academy of Sciences.

[10]  P. George-Hyslop.  Genetic factors in the genesis of Alzheimer's disease. , 2006 .

[11]  B. Winblad,et al.  Up-regulation of the inflammatory cytokines IFN-γ and IL-12 and down-regulation of IL-4 in cerebral cortex regions of APPSWE transgenic mice , 2002, Journal of Neuroimmunology.

[12]  B. Hyman,et al.  Acyl-coenzyme A: cholesterol acyltransferase modulates the generation of the amyloid β-peptide , 2001, Nature Cell Biology.

[13]  P. Bickford,et al.  Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats , 2000, Brain Research.

[14]  Kang Hu,et al.  High-Level Neuronal Expression of Aβ1–42 in Wild-Type Human Amyloid Protein Precursor Transgenic Mice: Synaptotoxicity without Plaque Formation , 2000, The Journal of Neuroscience.

[15]  Lars Bertram,et al.  New Frontiers in Alzheimer's Disease Genetics , 2001, Neuron.

[16]  J. Hardy,et al.  The Amyloid Hypothesis of Alzheimer ’ s Disease : Progress and Problems on the Road to Therapeutics , 2009 .

[17]  T B Shea,et al.  Calcium‐Activated Neutral Proteinase (Calpain) System in Aging and Alzheimer's Disease a , 1994, Annals of the New York Academy of Sciences.

[18]  John Q Trojanowski,et al.  ‘Unfolding’ pathways in neurodegenerative disease , 2003, Trends in Neurosciences.

[19]  R. Mrak,et al.  The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer’s disease , 2001, Neurobiology of Aging.

[20]  M. Ball,et al.  Gene expression profiling of 12633 genes in Alzheimer hippocampal CA1: Transcription and neurotrophic factor down‐regulation and up‐regulation of apoptotic and pro‐inflammatory signaling , 2002, Journal of neuroscience research.

[21]  H. Manev,et al.  Both aging and chronic fluoxetine increase S100B content in the mouse hippocampus , 2003, Neuroreport.

[22]  C. Holmes,et al.  Genotype and phenotype in Alzheimer's disease , 2002, British Journal of Psychiatry.

[23]  P. Mathews,et al.  The neuronal endosomal-lysosomal system in Alzheimer's disease. , 2001, Journal of Alzheimer's disease : JAD.

[24]  J. Poirier,et al.  Apolipoprotein E and Alzheimer's Disease A Role in Amyloid Catabolism , 2000, Annals of the New York Academy of Sciences.

[25]  J. Trojanowski,et al.  Expression profile of transcripts in Alzheimer's disease tangle‐bearing CA1 neurons , 2000, Annals of neurology.

[26]  L. Olson,et al.  Treatment strategies for neurodegenerative diseases based on trophic factors and cell transplantation techniques. , 1997, Journal of neural transmission. Supplementum.

[27]  R. Quirion,et al.  Alzheimer’s disease and the basal forebrain cholinergic system: relations to β-amyloid peptides, cognition, and treatment strategies , 2002, Progress in Neurobiology.

[28]  Mark P Mattson,et al.  Calcium signaling in the ER: its role in neuronal plasticity and neurodegenerative disorders , 2000, Trends in Neurosciences.

[29]  Eric J Topol,et al.  Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins , 2004, The Lancet.

[30]  P. Gasque,et al.  Activation of Complement in the Central Nervous System , 2003, Annals of the New York Academy of Sciences.